CARLSBAD, Calif. and PORT
WASHINGTON, N.Y., Oct. 5, 2016
/PRNewswire/ -- Verdezyne Inc., a synthetic biology
company producing biobased chemicals, and Aceto Corporation (ACET),
the leader in the marketing, sales and distribution of specialty
chemicals in the U.S., announced an agreement for sales and
distribution of Verdezyne's BIOLON® DDDA (biobased
dodecanedioic acid). BIOLON DDDA will be produced by Verdezyne and
will be distributed in the United States
of America by Aceto.
Verdezyne's BIOLON DDDA is produced more sustainably than
traditional petroleum-derived intermediate chemicals and will be
used to make a variety of end-user products including automotive
parts, coatings, cosmetics, and fragrances.
"The market is interested in high-quality renewable chemicals
such as our BIOLON, which can be used in the production of
high-performance nylon 6,12, molding resins, lubricants, adhesives
and powder coatings," said E. William
Radany, Ph.D., president and CEO of Verdezyne. "We are
excited to bring BIOLON to the U.S. market with Aceto, a highly
respected distributor of specialty chemicals. We are certain that
through this partnership we will be able to continue to provide
excellent customer service and high-quality products to the
market."
"Aceto is very excited to add BIOLON to our product offering of
polymer building blocks," commented Keith
Wilkinson, vice president, specialty chemicals Aceto. "We
are also excited to add a biobased product to our portfolio that
can be offered at competitive prices."
About Verdezyne
Verdezyne is a synthetic biology
company offering biobased chemicals developed using proprietary
metabolic pathway engineering tools. The company's first product,
BIOLON® DDDA, earned the USDA Certified Biobased
Product label, and is available worldwide. Current investors in
Verdezyne include BP Ventures, DSM Venturing B.V., OVP Venture
Partners, Monitor Ventures, and Sime
Darby. For more information, visit www.verdezyne.com or
connect with the company on Twitter, LinkedIn or
Facebook.
About Aceto Corporation
ACETO Corporation (NASDAQ:
ACET), incorporated in 1947 and with offices and operations in 10
countries, is engaged in the development, marketing, sale and
distribution of Human Health products (finished dosage form
generics and nutraceuticals), Pharmaceutical Ingredients
(pharmaceutical intermediates and active pharmaceutical
ingredients) and Performance Chemicals (specialty chemicals and
agricultural protection products).
For samples, orders or more information about Verdezyne's
BIOLON, please contact:
Keith Wilkinson
kwilkinson@aceto.com
Verdezyne Media Contacts:
Paula Page
paula@paulapagepr.com
650-279-3881
Jenna Ngian
Vice President, Global Sales and Supply Chain
JNgian@Verdezyne.com
760-707-5288
Aceto Corporation Media Contact:
Jody Burfening
jburfening@lhai.com
212-838-3777
Logo -
http://photos.prnewswire.com/prnh/20161003/414701LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/verdezyne-signs-distribution-agreement-with-aceto-corporation-300339416.html
SOURCE Verdezyne